Serum 25-hydroxyvitamin D levels throughout pregnancy: a longitudinal study in healthy and preeclamptic pregnant women

Background: Worldwide there is a high prevalence of 25-hydroxyvitamin D (25OHD) deficiency and has been associated with adverse outcomes during pregnancy. Objective: This is a nested, case–control study in a longitudinal cohort to compare the serum 25OHD levels and other biomarkers throughout pregn...

Full description

Bibliographic Details
Main Authors: Yessica Agudelo-Zapata, Luis Miguel Maldonado-Acosta, Héctor Fabio Sandoval-Alzate, Natalia Elvira Poveda, María Fernanda Garcés, Jonathan Alexander Cortés-Vásquez, Andrés Felipe Linares-Vaca, Carlos Alejandro Mancera-Rodríguez, Shahar Alexandra Perea-Ariza, Karen Yuliana Ramírez-Iriarte, Camilo Andrés Castro-Saldarriaga, Juan Manuel Arteaga-Diaz, Roberto Franco-Vega, Edith Ángel–Müller, Arturo José Parada-Baños, Jorge E Caminos
Format: Article
Language:English
Published: Bioscientifica 2018-05-01
Series:Endocrine Connections
Subjects:
Online Access:http://www.endocrineconnections.com/content/7/5/698.full
id doaj-9c0b62fbcab642b797e3a862a41d43f6
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yessica Agudelo-Zapata
Luis Miguel Maldonado-Acosta
Héctor Fabio Sandoval-Alzate
Natalia Elvira Poveda
María Fernanda Garcés
Jonathan Alexander Cortés-Vásquez
Andrés Felipe Linares-Vaca
Carlos Alejandro Mancera-Rodríguez
Shahar Alexandra Perea-Ariza
Karen Yuliana Ramírez-Iriarte
Camilo Andrés Castro-Saldarriaga
Juan Manuel Arteaga-Diaz
Roberto Franco-Vega
Edith Ángel–Müller
Arturo José Parada-Baños
Jorge E Caminos
spellingShingle Yessica Agudelo-Zapata
Luis Miguel Maldonado-Acosta
Héctor Fabio Sandoval-Alzate
Natalia Elvira Poveda
María Fernanda Garcés
Jonathan Alexander Cortés-Vásquez
Andrés Felipe Linares-Vaca
Carlos Alejandro Mancera-Rodríguez
Shahar Alexandra Perea-Ariza
Karen Yuliana Ramírez-Iriarte
Camilo Andrés Castro-Saldarriaga
Juan Manuel Arteaga-Diaz
Roberto Franco-Vega
Edith Ángel–Müller
Arturo José Parada-Baños
Jorge E Caminos
Serum 25-hydroxyvitamin D levels throughout pregnancy: a longitudinal study in healthy and preeclamptic pregnant women
Endocrine Connections
25 hydroxyvitamin D
pregnancy
preeclampsia
menstrual cycle
author_facet Yessica Agudelo-Zapata
Luis Miguel Maldonado-Acosta
Héctor Fabio Sandoval-Alzate
Natalia Elvira Poveda
María Fernanda Garcés
Jonathan Alexander Cortés-Vásquez
Andrés Felipe Linares-Vaca
Carlos Alejandro Mancera-Rodríguez
Shahar Alexandra Perea-Ariza
Karen Yuliana Ramírez-Iriarte
Camilo Andrés Castro-Saldarriaga
Juan Manuel Arteaga-Diaz
Roberto Franco-Vega
Edith Ángel–Müller
Arturo José Parada-Baños
Jorge E Caminos
author_sort Yessica Agudelo-Zapata
title Serum 25-hydroxyvitamin D levels throughout pregnancy: a longitudinal study in healthy and preeclamptic pregnant women
title_short Serum 25-hydroxyvitamin D levels throughout pregnancy: a longitudinal study in healthy and preeclamptic pregnant women
title_full Serum 25-hydroxyvitamin D levels throughout pregnancy: a longitudinal study in healthy and preeclamptic pregnant women
title_fullStr Serum 25-hydroxyvitamin D levels throughout pregnancy: a longitudinal study in healthy and preeclamptic pregnant women
title_full_unstemmed Serum 25-hydroxyvitamin D levels throughout pregnancy: a longitudinal study in healthy and preeclamptic pregnant women
title_sort serum 25-hydroxyvitamin d levels throughout pregnancy: a longitudinal study in healthy and preeclamptic pregnant women
publisher Bioscientifica
series Endocrine Connections
issn 2049-3614
2049-3614
publishDate 2018-05-01
description Background: Worldwide there is a high prevalence of 25-hydroxyvitamin D (25OHD) deficiency and has been associated with adverse outcomes during pregnancy. Objective: This is a nested, case–control study in a longitudinal cohort to compare the serum 25OHD levels and other biomarkers throughout pregnancy in a group of 20 preeclamptic women and 61 healthy pregnant women. An additional group of 29 healthy non-pregnant women were also studied during the two phases of the menstrual cycle. Results: Mean 25OHD levels in non-pregnant women were 31.9 ng/mL and 34.9 ng/mL during follicular and luteal phase, respectively (P < 0.01). Mean serum 25OHD levels in healthy pregnant women were 26.5, 30.1 and 31.9 ng/mL, at first, second and third trimester, respectively (P < 0.001). The first trimester levels of 25OHD were lower than those of healthy non-pregnant women (P < 0.001), showing a significant recovery at third trimester. In the group of healthy pregnant women, the 25OHD levels were 25.7 ng/mL and 27.2 ng/mL at 3 and 6 months postpartum, respectively; both values were lower than those observed in the non-pregnant women (P < 0.001). In preeclamptic women, 25OHD serum levels were similar to those of healthy pregnant women; nevertheless, they remained almost unchanged throughout pregnancy. Conclusion: There were no significant differences between healthy and preeclamptic pregnant women in terms of 25OHD levels throughout the pregnancy. Serum 25OHD levels in non-pregnant women were higher during luteal phase compared with follicular phase. The 25OHD levels of non-pregnant women tended to be higher than those of pregnant women.
topic 25 hydroxyvitamin D
pregnancy
preeclampsia
menstrual cycle
url http://www.endocrineconnections.com/content/7/5/698.full
work_keys_str_mv AT yessicaagudelozapata serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT luismiguelmaldonadoacosta serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT hectorfabiosandovalalzate serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT nataliaelvirapoveda serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT mariafernandagarces serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT jonathanalexandercortesvasquez serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT andresfelipelinaresvaca serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT carlosalejandromancerarodriguez serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT shaharalexandrapereaariza serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT karenyulianaramireziriarte serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT camiloandrescastrosaldarriaga serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT juanmanuelarteagadiaz serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT robertofrancovega serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT edithangelmuller serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT arturojoseparadabanos serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
AT jorgeecaminos serum25hydroxyvitamindlevelsthroughoutpregnancyalongitudinalstudyinhealthyandpreeclampticpregnantwomen
_version_ 1725932321341702144
spelling doaj-9c0b62fbcab642b797e3a862a41d43f62020-11-24T21:39:09ZengBioscientificaEndocrine Connections2049-36142049-36142018-05-0175698707https://doi.org/10.1530/EC-18-0055Serum 25-hydroxyvitamin D levels throughout pregnancy: a longitudinal study in healthy and preeclamptic pregnant womenYessica Agudelo-Zapata0Luis Miguel Maldonado-Acosta1Héctor Fabio Sandoval-Alzate2Natalia Elvira Poveda3María Fernanda Garcés4Jonathan Alexander Cortés-Vásquez5Andrés Felipe Linares-Vaca6Carlos Alejandro Mancera-Rodríguez7Shahar Alexandra Perea-Ariza8Karen Yuliana Ramírez-Iriarte9Camilo Andrés Castro-Saldarriaga10Juan Manuel Arteaga-Diaz11Roberto Franco-Vega12Edith Ángel–Müller13Arturo José Parada-Baños14Jorge E Caminos15Division of Endocrinology, Department of Internal Medicine, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDivision of Endocrinology, Department of Internal Medicine, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDepartment of Human Nutrition, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDepartment of Physiology, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDepartment of Physiology, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDepartment of Physiology, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDepartment of Physiology, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDepartment of Physiology, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDepartment of Physiology, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDepartment of Physiology, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDepartment of Physiology, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDivision of Endocrinology, Department of Internal Medicine, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDivision of Endocrinology, Department of Internal Medicine, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDepartment of Obstetrics and Gynecology, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDepartment of Obstetrics and Gynecology, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaDepartment of Physiology, School of Medicine, Universidad Nacional de Colombia, Bogotá, ColombiaBackground: Worldwide there is a high prevalence of 25-hydroxyvitamin D (25OHD) deficiency and has been associated with adverse outcomes during pregnancy. Objective: This is a nested, case–control study in a longitudinal cohort to compare the serum 25OHD levels and other biomarkers throughout pregnancy in a group of 20 preeclamptic women and 61 healthy pregnant women. An additional group of 29 healthy non-pregnant women were also studied during the two phases of the menstrual cycle. Results: Mean 25OHD levels in non-pregnant women were 31.9 ng/mL and 34.9 ng/mL during follicular and luteal phase, respectively (P < 0.01). Mean serum 25OHD levels in healthy pregnant women were 26.5, 30.1 and 31.9 ng/mL, at first, second and third trimester, respectively (P < 0.001). The first trimester levels of 25OHD were lower than those of healthy non-pregnant women (P < 0.001), showing a significant recovery at third trimester. In the group of healthy pregnant women, the 25OHD levels were 25.7 ng/mL and 27.2 ng/mL at 3 and 6 months postpartum, respectively; both values were lower than those observed in the non-pregnant women (P < 0.001). In preeclamptic women, 25OHD serum levels were similar to those of healthy pregnant women; nevertheless, they remained almost unchanged throughout pregnancy. Conclusion: There were no significant differences between healthy and preeclamptic pregnant women in terms of 25OHD levels throughout the pregnancy. Serum 25OHD levels in non-pregnant women were higher during luteal phase compared with follicular phase. The 25OHD levels of non-pregnant women tended to be higher than those of pregnant women.http://www.endocrineconnections.com/content/7/5/698.full25 hydroxyvitamin Dpregnancypreeclampsiamenstrual cycle